A Randomized, Open-Label Clinical Trial of Tasisulam Sodium Versus Paclitaxel as Second-Line Treatment in Patients With Metastatic Melanoma

Hamid, Omid; Ilaria, Robert, Jr.; Garbe, Claus; Wolter, Pascal; Maio, Michele; Hutson, Thomas E.; Arance, Ana; Lorigan, Paul; Lee, Jeeyun; Hauschild, Axel; Mohr, Peter; Hahka-Kemppinen, Marjo; Kaiser, Christopher; Turner, P. Kellie; Conti, Ilaria; Grob, Jean-Jacques

Publikationsdienste
→
Universitätsbibliographie
→
4 Medizinische Fakultät
→
Dokumentanzeige

« zurück

A Randomized, Open-Label Clinical Trial of Tasisulam Sodium Versus Paclitaxel as Second-Line Treatment in Patients With Metastatic Melanoma

Autor(en):

Hamid, Omid; Ilaria, Robert, Jr.; Garbe, Claus; Wolter, Pascal; Maio, Michele; Hutson, Thomas E.; Arance, Ana; Lorigan, Paul; Lee, Jeeyun; Hauschild, Axel; Mohr, Peter; Hahka-Kemppinen, Marjo; Kaiser, Christopher; Turner, P. Kellie; Conti, Ilaria; Grob, Jean-Jacques

Tübinger Autor(en):

Garbe, Claus

Erschienen in:

Cancer (2014), Bd. 120, H. 13, S. 2016-2024

Verlagsangabe:

Wiley - Blackwell

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1002/cncr.28635

ISSN:

0008-543X